Holen Sie sich die Stockscreener-App
104.80
4.08%
4.105
Handel nachbörslich:
105.00
0.20
+0.19%
Schlusskurs vom Vortag:
$100.69
Offen:
$101.08
24-Stunden-Volumen:
695.75K
Relative Volume:
0.81
Marktkapitalisierung:
$3.59B
Einnahmen:
$605.49M
Nettoeinkommen (Verlust:
$190.29M
KGV:
21.58
EPS:
4.8571
Netto-Cashflow:
$133.59M
1W Leistung:
+11.12%
1M Leistung:
-19.14%
6M Leistung:
-8.01%
1J Leistung:
+54.87%
1-Tages-Spanne:
$101.08
$106.06
1-Wochen-Bereich:
$95.46
$106.06
52-Wochen-Spanne:
$62.23
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
104.80 | 3.45B | 605.49M | 190.29M | 133.59M | 4.8571 |
ABT
Abbott Laboratories
|
102.30 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.30 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.28 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.19 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Hochstufung | Needham | Hold → Buy |
| 2025-10-13 | Eingeleitet | Jefferies | Buy |
| 2025-09-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-09-04 | Eingeleitet | Stifel | Hold |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
Evercore ISI Group Lowers Price Target for TransMedics Group (TM - GuruFocus
TransMedics Group, Inc. (TMDX) Stock forecasts - Yahoo Finance UK
TransMedics Group Inc (8T8.MU) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
TransMedics Group, Inc. (8T8.F) Stock Price, News, Quote & History - Yahoo! Finance Canada
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect | NDAQ:TMDX | Press Release - Stockhouse
TMDX Stock Price, Quote & Chart | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill
TransMedics’ clinical pipeline to drive next phase of growth - S&P Global
Investors who lost money on TransMedics Group, Inc.(TMDX) should - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Reach Out - ACCESS Newswire
Zevenbergen Capital Investments LLC Boosts Stock Position in TransMedics Group, Inc. $TMDX - marketbeat.com
TRANSMEDICS GROUP INC (TMDX) Fundamental Analysis & Valuation - ChartMill
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
TransMedics (TMDX) down 20.3% since last earnings report: Can it rebound? - MSN
TransMedics Group (TMDX) price target increased by 10.46% to 164.50 - MSN
[SCHEDULE 13G/A] TransMedics Group, Inc. Amended Passive Investment Disclosure - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
TransMedics Group (TMDX) Is Down 7.1% After Expanding Its National OCS Transplant Platform Ambitions - Yahoo Finance
TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
TransMedics Group (NASDAQ:TMDX) Shares Down 4.5%Here's What Happened - MarketBeat
Consider Keeping TransMedics Shares in Your Portfolio at This Time - Bitget
Reasons to Retain TransMedics Stock in Your Portfolio for Now - finance.yahoo.com
TransMedics Group, Inc. (TMDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
TransMedics Group (STU:TMDX) NonCurrent Deferred Revenue : €0.0 Mil (As of Dec. 2025) - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect - ACCESS Newswire
TransMedics Group Conference: CEO Outlines NOP Expansion, ENHANCE Trial Plans and Kidney Push - MarketBeat
2026-03-22 | Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Investors to Connect | NDAQ:TMDX | Press Release - Stockhouse
A Look At TransMedics Group (TMDX) Valuation After Share Pullback And Insider Selling Reports - simplywall.st
Stocks showing improved relative strength: TransMedics Group - MSN
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), HOYA (OtherHOCPF) and TransMedics Group (TMDX) - The Globe and Mail
Stifel Initiates Coverage of TransMedics Group (TMDX) with Hold Recommendation - MSN
TransMedics (TMDX) Faces Downward Pressure Amid Insider Selling and Market Concerns - GuruFocus
TransMedics Extends Decline as Selling Pressure Builds - GuruFocus
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
TransMedics Group (NASDAQ:TMDX) Trading Down 7.4%What's Next? - MarketBeat
Why TransMedics Group Stock Is Sliding Today - TipRanks
Morgan Stanley Maintains TransMedics Group (TMDX) Equal-Weight Recommendation - MSN
TransMedics Group Q4 2025 earnings preview - MSN
17,165 Shares in TransMedics Group, Inc. $TMDX Acquired by Kensington Investment Counsel LLC - MarketBeat
Q4 2025 Transmedics Group Inc Earnings Call Transcript - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Encourages TransMedics Group, Inc. (TMDX) Investors to Inquire about Securities Investigation - ACCESS Newswire
TransMedics Group, Inc. $TMDX Shares Bought by Fred Alger Management LLC - MarketBeat
Cowen Maintains Buy on TransMedics Group, Inc. (TMDX) March 2026 - Meyka
Aug Mood: Can TransMedics Group Inc expand its profit margins2026 Closing Moves & Verified Momentum Stock Watchlist - baoquankhu1.vn
Oppenheimer Raises Price Target for TransMedics Group (TMDX) to - GuruFocus
TransMedics Group, Inc. Trade Ideas — LS:A2PH5P - TradingView
Lovell, TransMedics director, sells $178k in TMDX stock By Investing.com - Investing.com Nigeria
TransMedics Group stock (ISIN: US89366D3075): FDA liver tailwind, kidney upside and European push re - AD HOC NEWS
TransMedics at Oppenheimer Conference: Strategic Expansion Unveiled By Investing.com - Investing.com South Africa
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):